Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PR
2601
Permian Resources
PR
$17.8B
| $1.39M | ﹤0.01% |
232,552
+116,957
| +101% | +$797K |
|
|
SGMO
2602
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.39M | ﹤0.01% |
184,826
+71,799
| +64% | +$624K |
|
2603
World Acceptance Corp
WRLD
$838M
| $1.38M | ﹤0.01% |
5,638
+2,226
| +65% | +$484K |
|
2604
James River Group Holdings
JRVR
$208M
| $1.38M | ﹤0.01% |
47,898
+15,907
| +50% | +$493K |
|
2605
CALL
Transocean
RIG
$5.89B
| $1.38M | ﹤0.01% |
500,000
| – | – |
|
|
KL
2606
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $1.38M | ﹤0.01% |
32,850
-76,235
| -70% | -$3.22M |
|
|
AMED
2607
DELISTED
Amedisys
AMED
| $1.38M | ﹤0.01% |
8,498
-23,900
| -74% | -$3.84M |
|
|
CSTR
2608
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $1.38M | ﹤0.01% |
65,349
+22,035
| +51% | +$474K |
|
|
DCPH
2609
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.37M | ﹤0.01% |
140,283
+76,704
| +121% | +$1.44M |
|
2610
Artivion
AORT
$1.3B
| $1.37M | ﹤0.01% |
67,316
+19,503
| +41% | +$393K |
|
2611
Icon
ICLR
$12.6B
| $1.37M | ﹤0.01% |
4,425
-8,404
| -66% | -$2.35M |
|
2612
Exelixis
EXEL
$13.3B
| $1.37M | ﹤0.01% |
74,882
-100,728
| -57% | -$1.93M |
|
|
HA
2613
DELISTED
Hawaiian Holdings, Inc.
HA
| $1.36M | ﹤0.01% |
74,143
+2,209
| +3% | +$44.7K |
|
2614
PDF Solutions
PDFS
$1.93B
| $1.36M | ﹤0.01% |
42,809
+15,428
| +56% | +$429K |
|
2615
Globus Medical
GMED
$10.7B
| $1.36M | ﹤0.01% |
18,828
-71,357
| -79% | -$5.18M |
|
2616
Curtiss-Wright
CW
$26.7B
| $1.36M | ﹤0.01% |
9,784
-12,322
| -56% | -$1.63M |
|
2617
Collegium Pharmaceutical
COLL
$1.15B
| $1.36M | ﹤0.01% |
72,591
-11,569
| -14% | -$226K |
|
2618
First Financial Corp
THFF
$958M
| $1.35M | ﹤0.01% |
29,905
+9,112
| +44% | +$401K |
|
2619
AngioDynamics
ANGO
$611M
| $1.35M | ﹤0.01% |
49,094
+9,836
| +25% | +$271K |
|
2620
Orthofix Medical
OFIX
$477M
| $1.35M | ﹤0.01% |
43,487
+14,139
| +48% | +$473K |
|
2621
Orion
OEC
$381M
| $1.35M | ﹤0.01% |
73,563
+42,963
| +140% | +$800K |
|
|
CS
2622
CALL
DELISTED
Credit Suisse Group
CS
| $1.35M | ﹤0.01% |
140,000
| – | – |
|
|
XRN
2623
Chiron Real Estate Inc
XRN
$514M
| $1.35M | ﹤0.01% |
15,198
+9,365
| +161% | +$771K |
|
2624
AMERISAFE
AMSF
$543M
| $1.35M | ﹤0.01% |
25,049
-11,532
| -32% | -$644K |
|
2625
Ashland
ASH
$3.33B
| $1.33M | ﹤0.01% |
12,387
-18,063
| -59% | -$1.82M |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.